Supplemental
Interest Paid
Royalty Pharma Interest Paid increased by 2497.3% to $173.53M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $138.82M to $173.53M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 20.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionSupplemental
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2017
Last reportedQ4 2025
How to read this metric
Increasing interest payments relative to debt levels may signal rising interest rates or a higher cost of borrowing.
Detailed definition
The total cash outflow for interest payments on debt obligations during the period. This metric highlights the cash cost...
Peer comparison
Used to compare the cost of debt and interest coverage ratios against industry peers.
Metric ID:
interest_paidHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $65.26M | $671.00K | $86.22M | $664.00K | $82.60M | $663.00K | $82.59M | $663.00K | $82.59M | $3.33M | $78.97M | $797.00K | $79.00M | $805.00K | $138.82M | $796.00K | $129.99M | $6.68M | $173.53M |
| QoQ Change | — | — | -99.0% | >999% | -99.2% | >999% | -99.2% | >999% | -99.2% | >999% | -96.0% | >999% | -99.0% | >999% | -99.0% | >999% | -99.4% | >999% | -94.9% | >999% |
| YoY Change | — | — | — | — | — | +26.6% | -1.2% | -4.2% | -0.2% | -0.0% | +401.8% | -4.4% | +20.2% | -4.3% | -75.8% | +75.8% | -0.1% | +64.6% | +729.9% | +25.0% |
Range$0.00 – $173.53M
Avg YoY Growth+83.6%
Median YoY Growth-0.0%
Interest Paid at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's interest paid?
- Royalty Pharma (RPRX) reported interest paid of $173.53M in Q1 2026.
- How has Royalty Pharma's interest paid changed year-over-year?
- Royalty Pharma's interest paid increased by 25.0% year-over-year, from $138.82M to $173.53M.
- What is the long-term trend for Royalty Pharma's interest paid?
- Over 4 years (2021 to 2025), Royalty Pharma's interest paid has grown at a 20.6% compound annual growth rate (CAGR), from $130.43M to $276.29M.
- What does interest paid mean?
- The total cash paid for interest on debt.